PNC Financial Services Group’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.6K Buy
13,052
+1,009
+8% +$3.25K ﹤0.01% 3399
2026
Q1
$34.7K Hold
12,043
– – ﹤0.01% 3429
2025
Q4
$49K Hold
12,043
– – ﹤0.01% 3228
2025
Q3
$42.8K Buy
12,043
+926
+8% +$3.35K ﹤0.01% 3297
2025
Q2
$30.3K Sell
11,117
-487
-4% -$1K ﹤0.01% 3367
2025
Q1
$19.5K Buy
11,604
+1,573
+16% +$4.4K ﹤0.01% 3551
2024
Q4
$16.4K Buy
10,031
+10,011
+50,055% +$29.9K ﹤0.01% 3622
2024
Q3
$83 Hold
20
– – ﹤0.01% 4730
2024
Q2
$109 Buy
20
+13
+186% +$104 ﹤0.01% 4713
2024
Q1
$70 Buy
+7
New +$52 ﹤0.01% 4654
2023
Q3
– Sell
-600
Closed -$3.58K – 4731
2023
Q2
$3.58K Hold
600
– – ﹤0.01% 4204
2023
Q1
$1.96K Hold
600
– – ﹤0.01% 4317
2022
Q4
$2.37K Hold
600
– – ﹤0.01% 4206
2022
Q3
$4K Hold
600
– – ﹤0.01% 4033
2022
Q2
$4K Hold
600
– – ﹤0.01% 4065
2022
Q1
$5K Sell
600
-45
-7% -$364 ﹤0.01% 4010
2021
Q4
$10K Hold
645
– – ﹤0.01% 3794
2021
Q3
$15K Sell
645
-555
-46% -$11.7K ﹤0.01% 3623
2021
Q2
$24K Buy
1,200
+600
+100% +$13.6K ﹤0.01% 3398
2021
Q1
$20K Buy
+600
New +$19.5K ﹤0.01% 3416

Other funds holding SANA

PNC Financial Services Group's SANA Position: Q2 2026 in Review

PNC Financial Services Group increased its Sana Biotechnology (SANA) stake by 8.4% in Q2 2026, buying an estimated $3.25K and bringing the position to 13,052 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

PNC Financial Services Group first reported a position in SANA in Q1 2021 and has held it in 20 quarters since. The position peaked at $49K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • PNC Financial Services Group held 13,052 shares of Sana Biotechnology worth $45.6K as of Q2 2026.
  • PNC Financial Services Group bought 1,009 Sana Biotechnology shares in Q2 2026, an estimated $3.25K.
  • Sana Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3399 holding.
  • PNC Financial Services Group first reported a position in Sana Biotechnology in Q1 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's Sana Biotechnology position peaked at $49K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.